Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
Authors
Keywords
-
Journal
Molecular Cancer
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-03
DOI
10.1186/s12943-021-01487-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer radioresistance may be overcome by osteopontin gene knocking out with CRISPR/Cas9 technique
- (2021) R.G. Behbahani et al. Cancer Radiotherapie
- CRISPR/Cas9 gene editing for curing sickle cell disease
- (2021) So Hyun Park et al. TRANSFUSION AND APHERESIS SCIENCE
- Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer
- (2021) Macus Hao-Ran Bao et al. Cell Reports
- Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer
- (2021) Jiahong Chen et al. Frontiers in Cell and Developmental Biology
- CRISPR/Cas9 screening identifies a kinetochore‐microtubule dependent mechanism for Aurora‐A inhibitor resistance in breast cancer
- (2021) Ailin Chen et al. Cancer Communications
- Leber Congenital Amaurosis Due to CEP290 Mutations – Severe Vision Impairment with a High Unmet Medical Need
- (2021) Bart P. Leroy et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Implementation of CRISPR/Cas9 Genome Editing to Generate Murine Lung Cancer Models That Depict the Mutational Landscape of Human Disease
- (2021) Oliver Hartmann et al. Frontiers in Cell and Developmental Biology
- Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
- (2021) Giulia Pavani et al. Blood Advances
- CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing β-catenin
- (2021) Chun Cheng et al. ONCOGENE
- CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
- (2021) Alessio Biagioni et al. Frontiers in Oncology
- Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALS
- (2021) Han-Xiang Deng et al. Communications Biology
- CRISPR/Cas9-mediated activation of CDH1 suppresses metastasis of breast cancer in rats
- (2021) Fatma Al-Mulhim et al. ELECTRONIC JOURNAL OF BIOTECHNOLOGY
- Application of CHyMErA Cas9-Cas12a combinatorial genome-editing platform for genetic interaction mapping and gene fragment deletion screening
- (2021) Michael Aregger et al. Nature Protocols
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
- (2021) Julian D. Gillmore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy
- (2021) Joan Bertolin et al. Nature Communications
- Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
- (2021) Burair A. Alsaihati et al. Nature Communications
- A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
- (2021) Sander A. L. Palit et al. Scientific Reports
- Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer
- (2021) Xiaoyu Zhao et al. CANCER RESEARCH
- Cytotoxic lymphocytes-related gene ITK from a systematic CRISPR screen could predict prognosis of ovarian cancer patients with distant metastasis
- (2021) Mengyao Xu et al. Journal of Translational Medicine
- Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells
- (2021) Sibel Gunes et al. MEDICAL ONCOLOGY
- Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
- (2021) Huimin Zhang et al. Molecular Cancer
- Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
- (2021) Chune Yu et al. ONCOGENE
- A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
- (2021) Sanju Sinha et al. Nature Communications
- Rapid and Sensitive Diagnosis of Drug-Resistant FLT3-F691L Mutation by CRISPR Detection
- (2021) Yin Liu et al. Frontiers in Molecular Biosciences
- CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
- (2020) Maarten H. Geurts et al. Cell Stem Cell
- In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer
- (2020) Stefano Annunziato et al. EMBO JOURNAL
- RNA-Targeting CRISPR–Cas Systems and Their Applications
- (2020) Michal Burmistrz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Correction to: Using a marine microalga as a chassis for polyethylene terephthalate (PET) degradation
- (2020) Daniel Moog et al. Microbial Cell Factories
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Conditional control of RNA-guided nucleic acid cleavage and gene editing
- (2020) Shao-Ru Wang et al. Nature Communications
- A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA
- (2020) Olivier G. de Jong et al. Nature Communications
- How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections
- (2020) Majid Taati Moghadam et al. Infection and Drug Resistance
- Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems
- (2020) Alan R. Davidson et al. Annual Review of Biochemistry
- CRISPR/Cas9-based genome editing in mice uncovers 13 testis- or epididymis-enriched genes individually dispensable for male reproduction
- (2020) Jiang Sun et al. BIOLOGY OF REPRODUCTION
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Profiling global cancer incidence and mortality by socioeconomic development
- (2020) Joannie Lortet‐Tieulent et al. INTERNATIONAL JOURNAL OF CANCER
- High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
- (2020) Ana Ricobaraza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform
- (2020) Thomas Gonatopoulos-Pournatzis et al. NATURE BIOTECHNOLOGY
- Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
- (2020) You Lu et al. NATURE MEDICINE
- Recent Advances in CRISPR/Cas9 Delivery Strategies
- (2020) Bon Ham Yip Biomolecules
- Progress and challenges towards CRISPR/Cas clinical translation
- (2020) Daniel Rosenblum et al. ADVANCED DRUG DELIVERY REVIEWS
- Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression
- (2020) Tanner Wiegand et al. Annual Review of Microbiology
- In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system
- (2020) Yili Chen et al. ANTIVIRAL RESEARCH
- The delivery challenge: fulfilling the promise of therapeutic genome editing
- (2020) Joost van Haasteren et al. NATURE BIOTECHNOLOGY
- Prediction-based highly sensitive CRISPR off-target validation using target-specific DNA enrichment
- (2020) Seung-Hun Kang et al. Nature Communications
- Precise and error-prone CRISPR-directed gene editing activity in human CD34+ cells varies widely among patient samples
- (2020) Shirin R. Modarai et al. GENE THERAPY
- Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
- (2020) Wenhui Zhu et al. Frontiers in Oncology
- In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer
- (2020) Linda K Rushworth et al. Life Science Alliance
- Generation of genetically tailored porcine liver cancer cells by CRISPR/Cas9 editing
- (2020) Lobna Elkhadragy et al. BIOTECHNIQUES
- Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
- (2020) Michael V. Zuccaro et al. CELL
- Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins
- (2020) Juan Mo et al. JOURNAL OF CLINICAL INVESTIGATION
- CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions
- (2020) Abu Hazafa et al. LIFE SCIENCES
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
- (2020) Haydar Frangoul et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction to: Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system
- (2019) Kaijian Ling et al. Journal of Ovarian Research
- CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression
- (2019) Ruya Zhao et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- CRISPResso2 provides accurate and rapid genome editing sequence analysis
- (2019) Kendell Clement et al. NATURE BIOTECHNOLOGY
- Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins
- (2019) Yalan Zhu et al. MOLECULAR CELL
- Inactivation of APOBEC3G gene in breast cancer cells using the CRISPR/Cas9 system
- (2019) Rita Mendes de Almeida et al. ANNALS OF MEDICINE
- CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
- (2019) Kornel Labun et al. NUCLEIC ACIDS RESEARCH
- Origins and evolution of CRISPR-Cas systems
- (2019) Eugene V. Koonin et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The effect of bacterial mutation rate on the evolution of CRISPR-Cas adaptive immunity
- (2019) Anne Chevallereau et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- In utero gene editing for monogenic lung disease
- (2019) Deepthi Alapati et al. Science Translational Medicine
- Impact of CXCR4 and CXCR7 knockout by CRISPR/Cas9 on the function of triple-negative breast cancer cells
- (2019) Meng Yang et al. OncoTargets and Therapy
- An overview of designing and selection of sgRNAs for precise genome editing by the CRISPR-Cas9 system in plants
- (2019) Ajay Prakash Uniyal et al. 3 Biotech
- CRISPR/Cas9-mediated genome editing reveals 30 testis-enriched genes dispensable for male fertility in mice†
- (2019) Yonggang Lu et al. BIOLOGY OF REPRODUCTION
- miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study
- (2019) Bethany N. Hannafon et al. BMC CANCER
- Battling CRISPR-Cas9 off-target genome editing
- (2019) Daisy Li et al. CELL BIOLOGY AND TOXICOLOGY
- Construction of Traf3 knockout liver cancer cell line using CRISPR/Cas9 system
- (2019) Wenbo Hu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CRISPR-Mediated Gene Editing: Scientific and Ethical Issues
- (2019) Jarrod Bailey TRENDS IN BIOTECHNOLOGY
- Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription
- (2019) Sabrina Y. Stanley et al. CELL
- Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairıng effect in human prostate cancer cell line PC-3
- (2019) Muhammet Burak Batır et al. MOLECULAR BIOLOGY REPORTS
- CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
- (2019) Lei Xu et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation
- (2019) Gozde Korkmaz et al. NUCLEIC ACIDS RESEARCH
- A glance at genome editing with CRISPR–Cas9 technology
- (2019) Antara Barman et al. CURRENT GENETICS
- CRISPR/Cas9-Mediated Knock-Out of KrasG12D Mutated Pancreatic Cancer Cell Lines
- (2019) Eva Lentsch et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids
- (2019) Johanna F Dekkers et al. JNCI-Journal of the National Cancer Institute
- Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases
- (2019) Odatha W. Kotagama et al. Biomed Research International
- Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects
- (2019) Yingjun Li et al. Frontiers in Microbiology
- Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
- (2019) Fengqian Chen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity
- (2018) Mariann Landsberger et al. CELL
- Ethical Issues Regarding CRISPR Mediated Genome Editing
- (2018) Zabta Khan Shinwari et al. CURRENT ISSUES IN MOLECULAR BIOLOGY
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology
- (2018) Yoshizumi Ishino et al. JOURNAL OF BACTERIOLOGY
- CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool
- (2018) Carolyn Brokowski et al. JOURNAL OF MOLECULAR BIOLOGY
- Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks
- (2018) Eva K. Brinkman et al. MOLECULAR CELL
- CRISPR/Cas9 for cancer research and therapy
- (2018) Tianzuo Zhan et al. SEMINARS IN CANCER BIOLOGY
- CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation
- (2018) Karina D. Rysenkova et al. Oncotarget
- A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.
- (2018) You Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and activity of programmed cell death-1 gene knockout engineered t cells in patients with previously treated advanced esophageal squamous cell carcinoma: An open-label, single-arm phase I study.
- (2018) Zhao Jing et al. JOURNAL OF CLINICAL ONCOLOGY
- PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures
- (2018) Daniel Gleditzsch et al. RNA Biology
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
- (2018) Rasmus O Bak et al. eLife
- Delivery systems of CRISPR/Cas9-based cancer gene therapy
- (2018) Alessio Biagioni et al. Journal of Biological Engineering
- Enabling genetic analysis of diverse bacteria with Mobile-CRISPRi
- (2018) Jason M. Peters et al. Nature Microbiology
- One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans
- (2017) Heidi C. Howard et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
- (2017) Chang Liu et al. JOURNAL OF CONTROLLED RELEASE
- Deciphering, Communicating, and Engineering the CRISPR PAM
- (2017) Ryan T. Leenay et al. JOURNAL OF MOLECULAR BIOLOGY
- CRISPR-P 2.0: An Improved CRISPR-Cas9 Tool for Genome Editing in Plants
- (2017) Hao Liu et al. Molecular Plant
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Unexpected mutations after CRISPR–Cas9 editing in vivo
- (2017) Kellie A Schaefer et al. NATURE METHODS
- Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors
- (2017) Hiromi Miura et al. Nature Protocols
- CRISPR-Cas9–based treatment of myocilin-associated glaucoma
- (2017) Ankur Jain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci
- (2017) Samuel Lessard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
- (2017) Niclas E. Bengtsson et al. Nature Communications
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- Disabling Cas9 by an anti-CRISPR DNA mimic
- (2017) Jiyung Shin et al. Science Advances
- Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos
- (2017) Zhuchi Tu et al. Scientific Reports
- CRISPR/Cas9-induced Targeted Mutagenesis and Gene Replacement to Generate Long-shelf Life Tomato Lines
- (2017) Qing-hui Yu et al. Scientific Reports
- CRISPR/Cas9 Immune System as a Tool for Genome Engineering
- (2016) Magdalena Hryhorowicz et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cas-analyzer: an online tool for assessing genome editing results using NGS data
- (2016) Jeongbin Park et al. BIOINFORMATICS
- Naturally Occurring Off-Switches for CRISPR-Cas9
- (2016) April Pawluk et al. CELL
- CRISPR gene-editing tested in a person for the first time
- (2016) David Cyranoski NATURE
- Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins
- (2016) Junho K Hur et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR/Cas9-mediated gene knockout in the mouse brain using in utero electroporation
- (2016) Yohei Shinmyo et al. Scientific Reports
- CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
- (2016) Shu Su et al. Scientific Reports
- CRISPR-ERA: a comprehensive design tool for CRISPR-mediated gene editing, repression and activation: Fig. 1.
- (2015) Honglei Liu et al. BIOINFORMATICS
- Translating cancer genomes and transcriptomes for precision oncology
- (2015) Sameek Roychowdhury et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer
- (2015) M Sachdeva et al. CANCER GENE THERAPY
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Targeted genome editing in primate embryos
- (2015) Xiangyu Guo et al. CELL RESEARCH
- Potential pitfalls of CRISPR/Cas9-mediated genome editing
- (2015) Rongxue Peng et al. FEBS Journal
- Deregulation of Immune Response Genes in Patients With Epstein-Barr Virus-Associated Gastric Cancer and Outcomes
- (2015) Sun Young Kim et al. GASTROENTEROLOGY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro
- (2015) Lina Quan et al. PLoS One
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Germline genome-editing research and its socioethical implications
- (2015) Tetsuya Ishii TRENDS IN MOLECULAR MEDICINE
- ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts
- (2015) Simona Valletta et al. Oncotarget
- Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons
- (2015) Chul-Yong Park et al. Cell Reports
- Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Eric W F W Alton et al. Lancet Respiratory Medicine
- CRISPR MultiTargeter: A Web Tool to Find Common and Unique CRISPR Single Guide RNA Targets in a Set of Similar Sequences
- (2015) Sergey V. Prykhozhij et al. PLoS One
- Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing
- (2015) Masakazu Hashimoto et al. Scientific Reports
- Genome editing assessment using CRISPR Genome Analyzer (CRISPR-GA)
- (2014) M. Guell et al. BIOINFORMATICS
- Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
- (2014) S. Bae et al. BIOINFORMATICS
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos
- (2014) Yuyu Niu et al. CELL
- Testicular defense systems: immune privilege and innate immunity
- (2014) Shutao Zhao et al. Cellular & Molecular Immunology
- Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
- (2014) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
- (2014) Hao Yin et al. NATURE BIOTECHNOLOGY
- Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects
- (2014) Bin Shen et al. NATURE METHODS
- E-CRISP: fast CRISPR target site identification
- (2014) Florian Heigwer et al. NATURE METHODS
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- CRISPRseek: A Bioconductor Package to Identify Target-Specific Guide RNAs for CRISPR-Cas9 Genome-Editing Systems
- (2014) Lihua J. Zhu et al. PLoS One
- International regulatory landscape and integration of corrective genome editing into in vitro fertilization
- (2014) Motoko Araki et al. Reproductive Biology and Endocrinology
- COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
- (2014) Thomas J Cradick et al. Molecular Therapy-Nucleic Acids
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Cas9 as a versatile tool for engineering biology
- (2013) Prashant Mali et al. NATURE METHODS
- Heritable genome editing in C. elegans via a CRISPR-Cas9 system
- (2013) Ari E Friedland et al. NATURE METHODS
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
- (2013) Angharad Lloyd et al. Frontiers in Immunology
- Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system
- (2012) Joe Bondy-Denomy et al. NATURE
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- The privileged immunity of immune privileged organs: the case of the eye
- (2012) Inbal Benhar et al. Frontiers in Immunology
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
- (2011) Elitza Deltcheva et al. NATURE
- Levels of Antibody against 11 Staphylococcus aureus Antigens in a Healthy Population
- (2010) P. Colque-Navarro et al. Clinical and Vaccine Immunology
- Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
- (2010) Chrystal U. Louis et al. JOURNAL OF IMMUNOTHERAPY
- Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
- (2008) S. J. J. Brouns et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now